psmarketresearch1’s blog

All about market research update

Physiotherapy Equipment Market Analysis, Trends, Growth and Demand, 2023


The global physiotherapy equipment market is significantly growing due to technological advancements, such as implanted devices, rehabilitation robots, exoskeleton, and others. The technological advancements, such as implanted devices, help to increase the patient’s comfort level and improve patient care. The increasing demand for home physiotherapy and portable physiotherapy equipment are also creating growth opportunities for the global physiotherapy equipment market. The massive unexplored market in the physiotherapy equipment industry of the developing economies is creating abundant growth opportunities for the physiotherapy equipment market to grow at a considerable rate during the forecast period.

Explore more or request TOC on “Global Physiotherapy Equipment Market” at:

In addition, the advanced research and development facilities, and innovative product developments by the companies are propelling the growth of the physiotherapy equipment industry. Physiotherapy is provided to restore the body functioning, as per the biomechanics and anatomical position of an individual. Physiotherapy includes electrotherapy, exercise therapy, hydrotherapy, and cryotherapy, which helps a patient to recover from medical conditions and improve his health.

On the basis of product, the physiotherapy market can be categorized as equipment and accessories, where equipment leads the market in terms of market size. Equipment is further segmented into ultrasound, continuous passive motion (CPM), hydrotherapy, electrical stimulation, heat therapy, and therapeutic exercises. Cryotherapy is a new technology, which is gaining popularity among athletes. Further, the accessories are segmented as orthoses and other assistive devices, such as wheel chairs and crutches.

Request for Report Sample at:

Geographically, North America is likely to dominate the global physiotherapy equipment market in the coming years, due to upsurge in geriatric population and increasing prevalence of cardiovascular and neurological diseases. Asia-Pacific is the fastest growing region in the global physiotherapy equipment market, due to increasing healthcare expenditure, presence of huge pool of patients, intensifying government support, and up surging prevalence of cardiovascular, musculoskeletal, and neurological diseases in the region. Moreover, the physiotherapy equipment market is growing due to increasing awareness among the population, and refining healthcare infrastructure in the emerging countries, such as India and China.

Some of the companies operating in the global physiotherapy equipment market are BTL Industries, Djo Global, Body Sport, HMS Medical Systems, Isokinetics Inc., ENRAF-Nonius B.V., EMS Physio Ltd., Patterson Companies Inc., and Morris Group Internationals.

Guidewires Market Size, Analysis, Trends, Challenges & Forecast to 2023


The global guidewires market is growing, due to the increase in minimally invasive procedures. The increasing aging population and chronic diseases is also fuelling the growth of the global market. Furthermore, the worldwide growing prevalence of cardiovascular procedures across various age groups results in more number of cases undergoing PCI (Percutaneous Coronary Interventions) procedures, which is boosting the growth of the global market.

Explore Report at:

A guidewire is a very thin tube on which catheter is placed, and it is inserted into the artery and moved towards the area of blockage. A guidewire helps in positioning, inserting, and moving catheter inside an artery to treat blockages. During the stenting procedure, a stent is placed over the balloon catheter, which is associated with a guidewire and then moved towards the blockage area in the artery. The balloon inflates inside the artery allowing the plaque to compress, leading to the opening of the artery. A stent then expands inside the artery and forms a scaffold. This allows artery to remain open, improve blood flow, and prevents reclosing of the artery. A coronary guidewire is inserted in care of coronary intervention procedure; whereas, peripheral guidewire is inserted in case of peripheral vascular intervention procedure.

Request for Report Sample at:

Some of the major companies operating in the global guidewires market are Abbott Laboratories, Terumo Corporation, ASAHI INTECC, Medtronic Inc., Cordis Corporation, Boston Scientific Corporation, Stryker, B. Braun, and Cook Medical.


HIV Diagnosis Market - Share, Analysis, Drivers, Growth Rate & Demand, 2023


The global HIV diagnosis market is likely to grow significantly during the forecast period, due to rising prevalence of HIV/AIDS, growing awareness leading to high number of blood donations and blood transfusions, and advantageous features of point of care instruments and kits. In addition, rising healthcare expenditure on HIV and related activities further contributes to the growth of the overall market. High cost of automated HIV diagnosis procedures and lack of skilled professionals are some of the key factors restraining the growth of global HIV diagnosis market.

Explore Report Sample at:

As per the findings of the research, based on products, consumables segment is the largest product category in the global HIV diagnosis market. Antibody test has been the largely performed test of the global HIV diagnosis market, followed by viral load, CD4, early infant diagnosis and viral identification. Diagnostic laboratories have been the largest end user of HIV diagnosis, followed by hospitals, research institutes and others.

The healthcare expenditure for the purpose of alleviating the potential epidemic situation of HIV, has increased over the past few years in many low and middle income as well as developing countries. According to the data published by UNAIDS, $19.0 billion was spent on the HIV and AIDS related activities in low- and middle-income countries in 2015, of which 57% came from domestic budgets of the governments of these countries. Considering the increasing incidence of HIV, the UNAIDS estimated that approximately $26.2 billion will be required to respond to the epidemic of HIV infection expected in 2020 and around $23.9 billion will be required for the same, in 2030. The variation in healthcare spending across regions is thought to be related to the relative burden of the disease in that region, which in case of Sub-Saharan Africa is significantly high. The overall healthcare spending on HIV and related activities has increased over the years, which in turn is expected to drive the growth of the global HIV diagnosis market.

Pre-Purchase Inquiry at:

Some of the key players in the global HIV diagnosis market include Siemens AG, F. Hoffman La Roche Ltd., Danaher Corporation, Abbott Laboratories, Ltd., Thermo-Fisher Scientific Inc., Merck KGaA, Becton, Dickinson & Company, Alere Inc., Bio-Rad Laboratories and Hologic Inc.

Medical Aesthetics Market - Analysis, Drivers, Growth Rate, Specifications and Forecast 2023


The global medical aesthetics market is likely to grow from $8.6 billion in 2016 to $19.4 billion by 2023. Advancement in laser technology, growing awareness among consumers, and health benefits of medical aesthetics procedures have been driving the global medical aesthetics market. The market is further expected to gain revenue due to shift in the preference from surgical to non-surgical procedures. There has been a significant growth in non-surgical medical spa procedures in the recent years, resulting from better technologies, such as intense pulsed light and advanced laser based aesthetics equipment.

Browse Report Sample at:

As per the findings of research, injectables held the largest share in the global market in 2016, primarily due to high sales of botulinum toxin. Topicals, the second largest medical aesthetics product segment, witnessed the highest growth during 2013 – 2016. The highest growth of topicals is attributed to their ability to treat several skin conditions without any usage of uncomfortable procedures. Beauty clinics and centers was the largest end user of the global medical aesthetics market in 2016., followed by spas and salons.

The medical aesthetics market has witnessed number of mergers and acquisitions and strategic alliances recently. In December 2016, Allergan Plc. acquired LifeCell, a medicine company of Acelity L.P. Inc., for a cash consideration of $2.9 billion. The acquisition is expected to combine LifeCell’s business of regenerative medicines with Allergan’s medical aesthetics business. Allergan aims to strengthen its presence in regenerative medicine business with this acquisition. In April 2016, the company also acquired Topokine Therapeutics, a private company developing topical medicines for fat reduction, for a total consideration of $85.0 million. Topokine Therapeutics’ XAF5 is in late-stage development for the treatment of steatoblepharon.

Access Report Overview:

Some of the other key players in the market include Allergan Plc, Valeant Pharmaceuticals International, Inc., ZELTIQ Aesthetics, Inc., Johnson & Johnson, Cutera Inc., Alma Lasers Ltd., Merz GmbH & Co. KGaA, Galderma S.A., Syneron Medical Ltd., Cynosure, Inc., Photomedex, Inc. and Lumenis Ltd.

Needle-Free Diabetes Management Market Drivers, Opportunities, and Challenges


The study suggests that the global needle free diabetes management market is likely to grow from $3,830.6 million in 2016 to $16.8 billion by 2025. With the explosive growth of needle-free treatment devices and the increasing awareness regarding the safety issues associated with needles, the needle-free diabetes management market is gaining traction. The growing need for development of safe needle-free diagnostic device has fueled the demand for continuous blood glucose monitoring across all regions worldwide.

Browse Report Sample at:

The factors driving the growth of the market include increasing awareness regarding the safety issues associated with needles and high prevalence of diabetes globally. Needle stick injury during insulin administration can lead to blood-borne pathogen transmission, and hence healthcare workers or patients experience anxiety, fear and emotional distress due to needle stick injury. The risk of needle stick injury is eliminated through needle-free diabetes management. Globally, approximately 16 billion injections are administered every year as per WHO; however, all the syringes and needles are not properly disposed of. This creates huge traction for needle-free diabetes management devices in the healthcare industry. The prevalence of diabetes is increasing due to the alteration in lifestyle and lack of access to preventive care. According to the International Diabetes Federation (IDF), about 415 million people worldwide were suffering from diabetes in 2015 and the number is expected to increase to 642 million by 2040. This reflects the growing need for improved diabetes management, for which needle-free diabetes management can be one of the prospective solutions.

Browse the Report Summary at:

The research states that the manufacturers in the needle-free diabetes management market are focusing continually on workflow enhancements and improving diabetes management and device performance. Currently, the healthcare cost is outpacing the government expenditure on healthcare. The development of technologically advanced diabetes management devices has become necessary to ensure increased healthcare efficiency and productivity. Some of the key players in the global market include Medtronic plc, Insulet Corporation, Tandem Diabetes Care, Inc., Inovio Pharmaceuticals, Inc., Pharmajet, Inc., Zogenix, Inc., Antares Pharma Inc., and Glide Pharmaceutical Technologies Ltd.

Protein A Resin Market - Analysis, Trends, Challenges and Forecast, 2023


The global protein A resin market is expected to witness considerable growth during the forecast period due to the increasing research and development activities and increasing prevalence of chronic diseases. High traction for monoclonal antibodies in biopharmaceutical industry is supporting the growth of the global market. The increasing demand for monoclonal antibodies has fueled the need for high capacity commercial scale purification of monoclonal antibodies. Protein A resins are designed for the simple and rapid purification of antibodies. Therefore, an increase in demand for monoclonal antibodies implies an increase in demand for protein A resins. The market for natural protein A resin was the larger than recombinant protein A resin market in 2015; however, recombinant protein A resin market is expected to witness the higher growth during the forecast period. Among the different matrix of the protein A resin chromatography, agarose-based matrix was the largest contributor to the global protein A resin revenue in 2015. Biopharmaceutical industry was the largest end user of the protein A resins in 2015, as most monoclonal antibody research development activities are carried out in this industry.

Explore more about “Global Protein A Resin Market” at:

Protein A, a 56 kDa surface protein, is found on the cell wall of Staphylococcus aureus bacterium. The protein has immunoglobulin-binding domains which bind to proteins, mostly immunoglobulin G (IgG). Protein A binds to the Fc region or Fab region of immunoglobulins, thus, increasingly being used for immune precipitation or antibody purification applications. Protein A ligand is used for the affinity chromatography step in commercial-scale production of monoclonal antibodies. The key factors driving the use of protein A resin for antibody purification are high antibody selectivity, increased antibody yield and excellent antibody purity, and ease of operation in large as well as small scale antibody purification.  

Explore Report Sample at:

The protein A resin market is expected to witness the highest growth in Asia-Pacific during the forecast period. The highest growth in the region is attributed to the increasing compliance for biosimilars and shifting global interest for expanding biopharmaceutical manufacturing capacities in the emerging economies of the region.

The key players operating in the global protein A resin market are General Electric Company, Thermo Fisher Scientific Inc., Merck KGaA, Tosoh Corporation, Repligen Corporation, Novasep, Expedeon Ltd., and GenScript.

Health IT Security Market Size, Trends, Growth and Demand, 2023


The global health IT security market is witnessing considerable growth due to stringent regulatory requirements and interconnected medical devices. Since the usage of interconnected medical device is continuously increasing, health IT security would play a major role in the safety of health information assembled and imparted from various smart devices to patients and care givers. Moreover, increasing use of mobile device, due to greater adoption of bring-your-own device policy, is supporting the growth of the market. The adoption of health IT security across the globe is increasing, owing to increasing number of healthcare data breeches. The market for healthcare IT security services segment is expected to grow at the faster rate compared to healthcare IT security products market in the forecasted period, as the end users in this market would require continuous support in the form of service to protect their IT infrastructure from increased advanced cyber-attacks.

Explore Report at:

The cloud security proposes new growth avenues of health IT security, and evolution of next generation IT security solution is expected to create opportunities for the market. In addition, massive unexplored market in developing economies are creating abundant opportunities for the health IT security market to grow at a significant rate in the coming years. However, limited cyber security professionals and limited spending on IT security are the key factors hampering the growth of the global market.

Information privacy and patient privacy are the major aspects of the well-functioning of healthcare environment. Cyber-attacks are increasing constantly around the globe. Hospital encounters major concern due to abundant cyber-attacks that impend the secrecy and safety of their data assets and enterprise IT systems. Healthcare organizations are expected to adhere various acts and regulations such as the Department of Defense Information Assurance Certification and Accreditation Process (DIACA), Health Insurance Portability and Accountability Act (HIPPA), and Payment Card Industry Data Security Standard (PCI-DSS). In addition, healthcare organizations are required to deploy advanced security solutions to address customer demand, to protect high value data and increase stringent regulatory requirements.

Explore Report Sample at:

The key players operating in the global market are IBM Corporation, Symantec Corporation, Trend Micro Incorporated, Oracle Corporation, EMC Corporation, SailPoint Technologies, Dell Inc., Hewlett Packard, AT&T, and Intel Corporation.